Hyponatremia: Classification and Diagnosis

Total Page:16

File Type:pdf, Size:1020Kb

Load more

HYPONATREMIA: CLASSIFICATION AND DIAGNOSIS NOAH CARPENTER, MD Dr. Noah Carpenter is a Thoracic and Peripheral Vascular Surgeon. He completed a Bachelor of Science in chemistry and medical school and training at the University of Manitoba. Dr. Carpenter completed surgical residency and fellowship at the University of Edmonton and Affiliated Hospitals in Edmonton, Alberta, and an additional Adult Cardiovascular and Thoracic Surgery fellowship at the University of Edinburgh, Scotland. He has specialized in microsurgical techniques, vascular endoscopy, laser and laparoscopic surgery in Brandon, Manitoba and Vancouver, British Columbia, Canada and in Colorado, Texas, and California. Dr. Carpenter has an Honorary Doctorate of Law from the University of Calgary, and was appointed a Citizen Ambassador to China, and has served as a member of the Native Physicians Association of Canada, the Canadian College of Health Service Executives, the Science Institute of the Northwest Territories, the Canada Science Council, and the International Society of Endovascular Surgeons, among others. He has been an inspiration to youth, motivating them to understand the importance of achieving higher education. ABSTRACT Hyponatremia is the most common disorder of body fluid and electrolyte balance, which can lead to a wide range of clinical symptoms that can be severe or even fatal. Many different conditions can lead to hyponatremia, imposing on health clinicians a high need to recognize the signs and symptoms, and to administer immediate treatment according to the latest medical research and guidelines. 1 NurseCe4Less.com Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. Continuing Education Credit Designation This educational activity is credited for 2.5 hours at completion of the activity. Statement of Learning Need The degree of severity and causes of hyponatremia are often underestimated by health clinicians. Clinicians need to know how to recognize hyponatremia and to distinguish it from false hyponatremia. The conditions that can lead to hyponatremia, how to recognize the conditions, and the proper administration of treatment are important clinical considerations. The latest research and guidelines for recognition and treatment of hyponatremia are key to planning a patient’s course of care. Course Purpose To provide health clinicians with knowledge of the conditions that can lead to hyponatremia, of how to recognize such conditions, and of the proper treatment. Target Audience Advanced Practice Registered Nurses, Registered Nurses, and other Interdisciplinary Health Team Members. Disclosures Noah Carpenter, MD, William Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. There is no commercial support. 2 NurseCe4Less.com Self-Assessment of Knowledge Pre-Test: 1. Hyponatremia is generally defined as a a. high or low blood sodium level. b. high calcium concentration. c. low blood sodium level or serum sodium concentration. d. low potassium level. 2. ___________ hyponatremia is defined as a biochemical finding of a serum sodium concentration <120 mmol/l. a. Severe b. Moderate c. Pseudo d. Mild 3. ______________ comprise the majority of patients who are diagnosed with hyponatremia. a. Males b. Elderly patients c. Adolescents d. Hospitalized patients 4. Acute hyponatremia exists when the condition is documented for a period of a. a week. b. 72 hours. c. at least 48 hours. d. less than 48 hours. 5. Hyponatremia is classified as _____________ if a person’s body fluid volume is low. a. asymptomatic b. euvolemic c. hypervolemic d. hypovolemic 3 NurseCe4Less.com Introduction Hyponatremia is the most frequent electrolyte disorder encountered by health clinicians. In hospitalized patients, the most common electrolyte disorder is hyponatremia, and the incidence of hyponatremia is significant. It can lead to symptoms that can range from mild to severe, or even fatal. The severity and causes of hyponatremia are often underestimated by health clinicians. The conditions that can lead to hyponatremia, how to recognize the conditions, and the proper administration of treatment are discussed in the following sections. The latest research and guidelines for recognition and treatment of hyponatremia are also raised. Definition and Etiology of Hyponatremia Hyponatremia is the most common electrolyte disorder in hospitalized patients associated with increased mortality and morbidity. It is generally defined as a low blood sodium level or serum sodium concentration < 136 mmol/l.1 Mild hyponatremia is defined as a serum sodium concentration between 130 to 134 mEq/L, moderate hyponatremia is defined as a serum sodium concentration between 120 to 129 mEq/L mmol/l, and severe hyponatremia is defined as a serum sodium concentration of < 120 mEq/L.2 The prevalence of hyponatremia is reportedly as high as 30% depending on the criteria for its diagnosis.3 The clinical setting and the patient population are relevant to hyponatremia prevalence, and the condition correlates with significant morbidity and mortality and will vary depending upon the disease states and medical conditions occurring when hyponatremia is diagnosed. Serum sodium levels that are significantly low or fluctuating can lead to serious outcomes, even death.3 Complications of hyponatremia are preventable if the condition is diagnosed early and appropriately treated. The cause of hyponatremia is important to diagnose correctly. If the etiology is not correctly understood the treatment may lead to worse clinical outcomes. There are multiple causes for decreased serum sodium levels. In patients with a diagnosis of the syndrome of inappropriate antidiuretic 4 NurseCe4Less.com hormone (SIADH) secretion and co-occurring gastrointestinal symptoms, i.e., nausea and vomiting, volume replacement may be a necessary priority of treatment. Clinicians should always keep in mind that the indiscriminate use of large volumes of intravenous normal saline could lead to worsened serum sodium levels in cases of elevated vasopressin levels.3 The incidence of hyponatremia depends in large part on the patient population. Clinical symptoms vary from asymptomatic to seizures and coma. It is important to determine the prevalence of this condition since multiple new drugs exist and there are clinical determinants leading to hyponatremia.3 Moderate-to-severe hyponatremia, in particular with rapid onset, corresponds with significant morbidity and mortality. There are many underlying disease states and multiple causes associated with hyponatremia.3 Individuals who have sodium levels that shift suddenly or are severely hyponatremic must be treated immediately to avoid serious health outcomes and death. Treatment outcomes depends on whether or not the affected person has co-occurring health issues, and the severity of clinical symptoms. A hyponatremic person may be asymptomatic or show severe symptoms, including seizures and coma.3 Medical professionals will need to determine the underlying cause of hyponatremia, such as a clinical condition or medication- induced etiology. In hospitalized patients the prevalence of hyponatremia has reportedly reached as high as 30% based upon diagnostic criteria, patient population and clinical setting.3 However, in some studies hyponatremia is not found to be as high in hospitalized patients as in earlier reports, which is believed to be due to improved surveillance through laboratory testing of patients on diuretics or drugs known to cause hyponatremia, i.e., those that act on the central nervous system (CNS).3 The elderly, those individuals 65 or greater years of age, comprise the majority of patients who are diagnosed with hyponatremia. Elderly who are prescribed diuretic therapy are at higher risk of becoming hyponatremic.3 However, in younger patients a finding of end stage renal disease (ESRD) was 5 NurseCe4Less.com the primary underlying condition related to the development of hyponatremia. In both elderly and young individuals, hyponatremia is typically a secondary condition.3 Diuretic medication is a well-known cause of hyponatremia therefore patient education of the signs and symptoms of low sodium levels and vigilant monitoring of blood sodium levels, patient fluid intake and conditions that could lead to electrolyte disturbances, such as vomiting and diarrhea, is essential to avoid complications related to hyponatremia.3 Hyponatremia occurs more frequently in females than males.4 People who are depressed and prescribed antidepressant medication, selective serotonin reuptake inhibitors (SSRIs) have been identified with hyponatremia.4 As noted previously, there are multiple factors that can lead to hyponatremia, such as excessive fluid intake.4 Clinicians need to be cautious when diagnosing the cause of hyponatremia and when selecting recommended treatment to prevent a worse complication related to hyponatremia. Classification of Hyponatremia A classification system of hyponatremia should be consistent and helpful for both differential diagnosis and treatment. Classification of hyponatremia is according to various factors, and clinicians should recognize that each classification has advantages and disadvantages depending on clinical settings and situations. Clinicians should also bear in mind that differential diagnosis of hyponatremia can be
Recommended publications
  • Hyponatremia and Hypernatremia MICHAEL M

    Hyponatremia and Hypernatremia MICHAEL M

    This is a corrected version of the article that appeared in print. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia MICHAEL M. BRAUN, DO, Madigan Army Medical Center, Tacoma, Washington CRAIG H. BARSTOW, MD, Womack Army Medical Center, Fort Bragg, North Carolina NATASHA J. PYZOCHA, DO, Madigan Army Medical Center, Tacoma, Washington Hyponatremia and hypernatremia are common findings in the inpatient and outpatient settings. Sodium disorders are associated with an increased risk of morbidity and mortality. Plasma osmolality plays a critical role in the patho- physiology and treatment of sodium disorders. Hyponatremia and hypernatremia are classified based on volume status (hypovolemia, euvolemia, and hypervolemia). Sodium disorders are diagnosed by findings from the history, physical examination, laboratory studies, and evaluation of volume status. Treatment is based on symptoms and underlying causes. In general, hyponatremia is treated with fluid restriction (in the setting of euvolemia), isotonic saline (in hypovolemia), and diuresis (in hypervolemia). A combination of these therapies may be needed based on the presentation. Hypertonic saline is used to treat severe symptomatic hyponatremia. Medications such as vaptans may have a role in the treatment of euvolemic and hypervolemic hyponatremia. The treatment of hypernatremia involves correcting the underlying cause and correcting the free water deficit. Am( Fam Physician. 2015;91(5):299-307. Copy- right © 2015 American Academy of Family Physicians.) More online yponatremia is a common elec- a worse prognosis in patients with liver cir- at http://www. trolyte disorder defined as a rhosis, pulmonary hypertension, myocardial aafp.org/afp. serum sodium level of less than infarction, chronic kidney disease, hip frac- CME This clinical content 135 mEq per L.1-3 A Dutch sys- tures, and pulmonary embolism.1,8-10 conforms to AAFP criteria Htematic review of 53 studies showed that the for continuing medical Etiology and Pathophysiology education (CME).
  • CURRENT Essentials of Nephrology & Hypertension

    a LANGE medical book CURRENT ESSENTIALS: NEPHROLOGY & HYPERTENSION Edited by Edgar V. Lerma, MD Clinical Associate Professor of Medicine Section of Nephrology Department of Internal Medicine University of Illinois at Chicago College of Medicine Associates in Nephrology, SC Chicago, Illinois Jeffrey S. Berns, MD Professor of Medicine and Pediatrics Associate Dean for Graduate Medical Education The Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania Allen R. Nissenson, MD Emeritus Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, California Chief Medical Offi cer DaVita Inc. El Segundo, California New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Lerma_FM_p00i-xvi.indd i 4/27/12 10:33 AM Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-180858-3 MHID: 0-07-180858-2 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-144903-8, MHID: 0-07-144903-5. All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefi t of the trademark owner, with no intention of infringement of the trademark.
  • Cerebral Salt Wasting Syndrome and Systemic Lupus Erythematosus: Case Report

    Cerebral Salt Wasting Syndrome and Systemic Lupus Erythematosus: Case Report

    Elmer ress Case Report J Med Cases. 2016;7(9):399-402 Cerebral Salt Wasting Syndrome and Systemic Lupus Erythematosus: Case Report Filipe Martinsa, c, Carolina Ouriquea, Jose Faria da Costaa, Joao Nuakb, Vitor Braza, Edite Pereiraa, Antonio Sarmentob, Jorge Almeidaa Abstract disorders, that results in hyponatremia and a decrease in ex- tracellular fluid volume. It is characterized by a hypotonic hy- Cerebral salt wasting (CSW) is a rare cause of hypoosmolar hypona- ponatremia with inappropriately elevated urine sodium con- tremia usually associated with acute intracranial disease character- centration in the setting of a normal kidney function [1-3]. ized by extracellular volume depletion due to inappropriate sodium The onset of this disorder is typically seen within the first wasting in the urine. We report a case of a 46-year-old male with 10 days following a neurological insult and usually lasts no recently diagnosed systemic lupus erythematosus (SLE) initially pre- more than 1 week [1, 2]. Pathophysiology is not completely senting with neurological involvement and an antiphospholipid syn- understood but the major mechanism might be the inappropri- drome (APS) who was admitted because of chronic asymptomatic ate and excessive release of natriuretic peptides which would hyponatremia previously assumed as secondary to syndrome of inap- result in natriuresis and volume depletion. A secondary neu- propriate antidiuretic hormone secretion (SIADH). Initial evaluation rohormonal response would result in an increase in the renin- revealed a hypoosmolar hyponatremia with high urine osmolality angiotensin system and consequently in antidiuretic hormone and elevated urinary sodium concentration. Clinically, the patient’s (ADH) production. Since the volume stimulus is more potent extracellular volume status was difficult to define accurately.
  • Electrolyte and Acid-Base

    Electrolyte and Acid-Base

    Special Feature American Society of Nephrology Quiz and Questionnaire 2013: Electrolyte and Acid-Base Biff F. Palmer,* Mark A. Perazella,† and Michael J. Choi‡ Abstract The Nephrology Quiz and Questionnaire (NQ&Q) remains an extremely popular session for attendees of the annual meeting of the American Society of Nephrology. As in past years, the conference hall was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, *Department of Internal Medicine, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories University of Texas along with single-best-answer questions were prepared by a panel of experts. Prior to the meeting, program Southwestern Medical directors of United States nephrology training programs answered questions through an Internet-based ques- Center, Dallas, Texas; † tionnaire. A new addition to the NQ&Q was participation in the questionnaire by nephrology fellows. To review Department of Internal Medicine, the process, members of the audience test their knowledge and judgment on a series of case-oriented questions Yale University School prepared and discussed by experts. Their answers are compared in real time using audience response devices with of Medicine, New the answers of nephrology fellows and training program directors. The correct and incorrect answers are then Haven, Connecticut; ‡ briefly discussed after the audience responses, and the results of the questionnaire are displayed. This article and Division of recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases Nephrology, Department of and expert discussions. Medicine, Johns Clin J Am Soc Nephrol 9: 1132–1137, 2014.
  • Electrolyte and Acid-Base Disorders Triggered by Aminoglycoside Or Colistin Therapy: a Systematic Review

    Electrolyte and Acid-Base Disorders Triggered by Aminoglycoside Or Colistin Therapy: a Systematic Review

    antibiotics Review Electrolyte and Acid-Base Disorders Triggered by Aminoglycoside or Colistin Therapy: A Systematic Review Martin Scoglio 1,* , Gabriel Bronz 1, Pietro O. Rinoldi 1,2, Pietro B. Faré 3,Céline Betti 1,2, Mario G. Bianchetti 1, Giacomo D. Simonetti 1,2, Viola Gennaro 1, Samuele Renzi 4, Sebastiano A. G. Lava 5 and Gregorio P. Milani 2,6,7 1 Faculty of Biomedicine, Università della Svizzera Italiana, 6900 Lugano, Switzerland; [email protected] (G.B.); [email protected] (P.O.R.); [email protected] (C.B.); [email protected] (M.G.B.); [email protected] (G.D.S.); [email protected] (V.G.) 2 Department of Pediatrics, Pediatric Institute of Southern Switzerland, Ospedale San Giovanni, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland; [email protected] 3 Department of Internal Medicine, Ospedale La Carità, Ente Ospedaliero Cantonale, 6600 Locarno, Switzerland; [email protected] 4 Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; [email protected] 5 Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, 1011 Lausanne, Switzerland; [email protected] 6 Pediatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy 7 Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy * Correspondence: [email protected] Citation: Scoglio, M.; Bronz, G.; Abstract: Aminoglycoside or colistin therapy may alter the renal tubular function without decreasing Rinoldi, P.O.; Faré, P.B.; Betti, C.; the glomerular filtration rate. This association has never been extensively investigated.
  • Is There a Relationship Between COVID-19 and Hyponatremia?

    Is There a Relationship Between COVID-19 and Hyponatremia?

    medicina Review Is There a Relationship between COVID-19 and Hyponatremia? Gina Gheorghe 1,2,†, Madalina Ilie 1,2, Simona Bungau 3,† , Anca Mihaela Pantea Stoian 4 , Nicolae Bacalbasa 5 and Camelia Cristina Diaconu 6,7,* 1 Department of Gastroenterology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; [email protected] (G.G.); [email protected] (M.I.) 2 Department of Gastroenterology, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania 3 Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania; [email protected] 4 Department of Diabetes, Nutrition and Metabolic Diseases, “Carol Davila” University of Medicine and Pharmacy, 020475 Bucharest, Romania; [email protected] 5 Department of Visceral Surgery, Center of Excellence in Translational Medicine, Fundeni Clinical Institute, 022328 Bucharest, Romania; [email protected] 6 Department of Internal Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania 7 Department of Internal Medicine, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania * Correspondence: [email protected]; Tel.: +40-0726-377-300 † This author has equal contribution to the paper as the first author. Abstract: Nowadays, humanity faces one of the most serious health crises, the severe acute respi- ratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The severity of coronavirus disease 2019 (COVID-19) pandemic is related to the high rate of interhuman transmission of the virus, variability of clinical presentation, and the absence of specific therapeutic methods. COVID-19 can manifest with non-specific symptoms and signs, especially among the elderly. In some cases, the clinical manifestations of hyponatremia may be the first to appear.
  • Parenteral Nutrition Primer: Balance Acid-Base, Fluid and Electrolytes

    Parenteral Nutrition Primer: Balance Acid-Base, Fluid and Electrolytes

    Parenteral Nutrition Primer: Balancing Acid-Base, Fluids and Electrolytes Phil Ayers, PharmD, BCNSP, FASHP Todd W. Canada, PharmD, BCNSP, FASHP, FTSHP Michael Kraft, PharmD, BCNSP Gordon S. Sacks, Pharm.D., BCNSP, FCCP Disclosure . The program chair and presenters for this continuing education activity have reported no relevant financial relationships, except: . Phil Ayers - ASPEN: Board Member/Advisory Panel; B Braun: Consultant; Baxter: Consultant; Fresenius Kabi: Consultant; Janssen: Consultant; Mallinckrodt: Consultant . Todd Canada - Fresenius Kabi: Board Member/Advisory Panel, Consultant, Speaker's Bureau • Michael Kraft - Rockwell Medical: Consultant; Fresenius Kabi: Advisory Board; B. Braun: Advisory Board; Takeda Pharmaceuticals: Speaker’s Bureau (spouse) . Gordon Sacks - Grant Support: Fresenius Kabi Sodium Disorders and Fluid Balance Gordon S. Sacks, Pharm.D., BCNSP Professor and Department Head Department of Pharmacy Practice Harrison School of Pharmacy Auburn University Learning Objectives Upon completion of this session, the learner will be able to: 1. Differentiate between hypovolemic, euvolemic, and hypervolemic hyponatremia 2. Recommend appropriate changes in nutrition support formulations when hyponatremia occurs 3. Identify drug-induced causes of hypo- and hypernatremia No sodium for you! Presentation Outline . Overview of sodium and water . Dehydration vs. Volume Depletion . Water requirements & Equations . Hyponatremia • Hypotonic o Hypovolemic o Euvolemic o Hypervolemic . Hypernatremia • Hypovolemic • Euvolemic • Hypervolemic Sodium and Fluid Balance . Helpful hint: total body sodium determines volume status, not sodium status . Examples of this concept • Hypervolemic – too much volume • Hypovolemic – too little volume • Euvolemic – normal volume Water Distribution . Total body water content varies from 50-70% of body weight • Dependent on lean body mass: fat ratio o Fat water content is ~10% compared to ~75% for muscle mass .
  • ACP NATIONAL ABSTRACTS COMPETITIONS MEDICAL STUDENTS 2019 Table of Contents

    ACP NATIONAL ABSTRACTS COMPETITIONS MEDICAL STUDENTS 2019 Table of Contents

    ACP NATIONAL ABSTRACTS COMPETITIONS MEDICAL STUDENTS 2019 Table of Contents MEDICAL STUDENT RESEARCH PODIUM PRESENTATIONS ...................................................................... 8 COLOMBIA RESEARCH PODIUM PRESENTATION - Andrey Sanko ........................................................ 9 Clinical Factors Associated with High Glycemic Variability Defined by the Variation Coefficient in Patients with Type 2 Diabetes .......................................................................................................... 9 MARYLAND RESEARCH PODIUM PRESENTATION - Asmi Panigrahi ................................................... 11 Influence of Individual-Level Neighborhood Factors on Health Promoting and Risk Behaviors in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) ........................................... 11 NEW YORK RESEARCH PODIUM PRESENTATION - Kathryn M Linder ................................................ 13 Implementation of a Medical Student-Led Emergency Absentee Ballot Voting Initiative at an Urban Tertiary Care University Hospital ......................................................................................... 13 OREGON RESEARCH PODIUM PRESENTATION - Sherry Liang ............................................................ 15 A Novel Student-Led Improvement Science Curriculum for Pre-Clinical Medical Students .......... 15 TENNESSEE RESEARCH PODIUM PRESENTATION - Zara Latif ............................................................. 17 Impaired Brain Cells Response in Obesity
  • Serum Sodium Concentration [Na+] Less Than 135 Meq/L. INCIDENCE

    Serum Sodium Concentration [Na+] Less Than 135 Meq/L. INCIDENCE

    HYPONATREMIA DEFINITION: Serum sodium concentration [Na+] less than 135 mEq/L. INCIDENCE IN CRITICAL ILLNESS: 30%. (The most common electrolyte abnormality encountered in clinical medicine.) ETIOLOGY: Hypo-osmolar hyponatremia: Serum osmolality is low (< 280 mOsm/kg H2O). Hypovolemic: Total body water deficit + greater degree of total body sodium deficit. o Renal losses (urine [Na+] > 20 mmol/L): Diuretic excess; mineralocorticoid deficiency; cerebral salt wasting; bicarbonaturia (renal tubular acidosis and metabolic alkalosis); ketonuria; osmotic diuresis. o Extrarenal losses (urine [Na+] < 20 mmol/L): Vomiting; diarrhea; “third spacing” (burns, pancreatitis, trauma). Euvolemic: Total body water excess + normal total body sodium. o The most common subcategory of hyponatremia. o Includes dilutional hyponatremia. Excess of water relative to sodium; serum chloride concentration is usually normal. o Includes SIADH: Diagnosis of exclusion. Inclusion criteria are plasma osmolality < 270 mOsm/kg + H2O; urine osmolality > 100 mOsm/kg H2O; euvolemia; urine [Na ] elevated; adrenal, thyroid, pituitary, renal insufficiency absent; diuretic use absent. o Urine [Na+] is typically > 20 mmol/L. o Glucocorticoid deficiency; hypothyroidism; stress; medications (vasopressin analogs, drugs that enhance vasopressin release, drugs that potentiate renal action of vasopressin, haloperidol, amitriptyline, other psychotropic medications). Hypervolemic: Total body water excess >>> total body sodium excess. o Urine [Na+] > 20 mmol/L: Renal failure. o Urine
  • The Prognostic Effects of Hyponatremia and Hyperchloremia on Postoperative NSCLC Patients

    The Prognostic Effects of Hyponatremia and Hyperchloremia on Postoperative NSCLC Patients

    Current Problems in Cancer 43 (2019) 402–410 Contents lists available at ScienceDirect Current Problems in Cancer journal homepage: www.elsevier.com/locate/cpcancer The prognostic effects of hyponatremia and hyperchloremia on postoperative NSCLC patients Wei Li a,b,1, Xiaowei Chen a,1, Liguang Wang a,c, Yu Wang a, ∗ Cuicui Huang a, Guanghui Wang a,d, Jiajun Du a,d, a Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, PR China b Department of Thoracic Surgery, Shandong Juxian People’s Hospital, Rizhao, PR China c Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, PR China d Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, PR China a b s t r a c t Electrolytic disorders are common in lung cancer patients. But the association between serum electrolytes levels and survival in patients undergoing lung cancer resections for non–small-cell lung cancer (NSCLC) has been poorly inves- tigated. A retrospective study was conducted on consecutive postoperative NSCLC patients. Pearson’s test was used to determine the association between serum sodium and chlorine levels and clinical characteristics, and cox regression and Kaplan-Meier model were applied to analyze risk factors on overall survival. We found that hyponatremia was an independent prognostic factor associated with poor prognosis in NSCLC patients undergoing complete resection (log-rank test, P = 0.004). In addition, we found that hyperchloremia predicted a poor clinical outcome in patients with non-anion-gap (log-rank test, P = 0.011), whereas it predicted a favorable clinical outcome in patients with high- anion-gap (log-rank test, P = 0.002).
  • Severe Hyponatremia in a COVID-19 Patient

    Severe Hyponatremia in a COVID-19 Patient

    http://crim.sciedupress.com Case Reports in Internal Medicine 2020, Vol. 7, No. 3 CASE REPORTS Severe hyponatremia in a COVID-19 patient Waqar Haider Gaba∗1, Sara Al Hebsi2, Rania Abu Rahma3 1Consultant Physician Internal Medicine, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates 2Medical Resident Internal Medicine, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates 3Nephrology Specialist, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates Received: August 13, 2020 Accepted: August 31, 2020 Online Published: September 23, 2020 DOI: 10.5430/crim.v7n3p15 URL: https://doi.org/10.5430/crim.v7n3p15 ABSTRACT Hyponatremia is one of the most common electrolyte abnormalities found in hospitalized patients. The diagnosis of the underlying cause of hyponatremia could be challenging. However, common causes include the syndrome of inappropriate anti-diuretic hormone (SIADH), diuretic use, polydipsia, adrenal insufficiency, hypovolemia, heart failure, and liver cirrhosis. The ongoing pandemic of coronavirus disease 2019 (COVID-19) can present with severe hyponatremia. The association of hyponatremia and COVID-19 infection has been described, though pathophysiology is not clear. Here we describe a case of a 61-year-old male who presented with severe hyponatremia (Na+ 100 mmol/L) thought to be secondary to SIADH associated with COVID-19 pneumonia. Key Words: Hyponatremia, COVID-19, Syndrome of Inappropriate Antidiuretic Hormone (SIADH) 1.I NTRODUCTION sense RNA virus. It causes mild respiratory symptoms simi- lar to a common cold. Around 50% of COVID-19 positive Hyponatremia is defined as a serum sodium concentration patients were found to have hyponatremia on admission.[2] < 135 mEq/L. Clinical presentation could vary from mild to severe or life-threatening.
  • Hypercalcemia and Hyponatremia

    Hypercalcemia and Hyponatremia

    Hypercalcemia and Hyponatremia Santosh Reddy MD FACP Assistant Professor Scott & White/Texas A&M Etiology of Hypercalcemia Hypercalcemia results when the entry of calcium into the circulation exceeds the excretion of calcium into the urine or deposition in bone. Sources of calcium are most commonly the bone or the gastrointestinal tract Etiology Hypercalcemia is a relatively common clinical problem. Elevation in the physiologically important ionized (or free) calcium concentration. However, 40 to 45 percent of the calcium in serum is bound to protein, principally albumin; , increased protein binding causes elevation in the serum total calcium. Increased bone resorption Primary and secondary hyperparathyroidism Malignancy Hyperthyroidism Other - Paget's disease, estrogens or antiestrogens in metastatic breast cancer, hypervitaminosis A, retinoic acid Increased intestinal calcium absorption Increased calcium intake Renal failure (often with vitamin D supplementation) Milk-alkali syndrome Hypervitaminosis D Enhanced intake of vitamin D or metabolites Chronic granulomatous diseases (eg, sarcoidosis) Malignant lymphoma Acromegaly Pseudocalcemia Hyperalbuminemia 1) severe dehydration 2) multiple myeloma who have a calcium- binding paraprotein. This phenomenon is called pseudohypercalcemia (or factitious hypercalcemia) Other causes Familial hypocalciuric hypercalcemia Chronic lithium intake Thiazide diuretics Pheochromocytoma Adrenal insufficiency Rhabdomyolysis and acute renal failure Theophylline toxicity Immobilization